Status:
COMPLETED
Thrombin Generation Numerical Models Validation in Haemophilic Case
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Collaborating Sponsors:
Pfizer
Saint Etienne School of Mine
Conditions:
Haemophilia B
Haemophilia A
Eligibility:
MALE
18-45 years
Brief Summary
Personalized therapy in haemophilia has not been reached yet. Treatment is substitutive and its doses are only based on the levels of deficient factor VIII (for haemophilia A) or IX (for haemophilia B...
Eligibility Criteria
Inclusion
- Signed consent form
- Age between 18 and 45 years old
- Male
- no smoker
Exclusion
- other clinical research protocol participation during the 3 months before inclusion
- Personal or familial history of hemorrhagic disease (parents, brothers and sisters
- Personal history of thrombosis (arterial or venous)
- Familial history of thrombosis before 45 years old (parents, brothers and sisters)
- Drug treatments of aspirin or anti-inflammatory type during the week before sampling
- Surgery the month before sampling
- Chronic pathology responsible for inflammatory syndrome
- Infectious episode in course
Key Trial Info
Start Date :
March 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02300519
Start Date
March 1 2015
End Date
July 1 2015
Last Update
August 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Saint-Etienne
Saint-Etienne, France, 42055